Article
Adult mice are unresponsive to AAV8-Gremlin1 gene therapy targeting the liver
19 Feb 2021
Abstract excerpt
OBJECTIVE: Gremlin 1 (GREM1) is a secreted BMP2/4 inhibitor which regulates commitment and differentiation of human adipose precursor cells and prevents the browning effect of BMP4. GREM1 is an insulin antagonist and serum levels are high in type 2 diabetes (T2D). We here examined in vivo effects of AAV8 (Adeno-Associated Viral vectors of serotype eight) GREM 1 targeting the liver in mature mice to increase its...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
